Cargando…
Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
Autores principales: | Ripoll, Èlia, de Ramon, Laura, Draibe, Juliana, Merino, Ana, Bolaños, Nuria, Goma, Montse, Cruzado, Josep M., Grinyó, Josep M., Torras, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930563/ https://www.ncbi.nlm.nih.gov/pubmed/27368974 http://dx.doi.org/10.1186/s13075-016-1058-2 |
Ejemplares similares
-
JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016) -
CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013) -
Correction: CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013) -
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
por: Guiteras, Jordi, et al.
Publicado: (2021) -
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
por: Guiteras, Jordi, et al.
Publicado: (2022)